Search

Eric E Boros

from Chapel Hill, NC
Age ~62
Get Report
Also known as:
Eric Eugene Boros, Eric S Boros, Eric E Eric
Phone and address:
824 Mountain Creek Rd, Chapel Hill, NC 27516
(919) 942-1723
Related to:
Meghan D Mccarthy, 45Christie H Boros, 59Nancy L Boros, 83Emily A Boros, 36Eugene J Boros, 84
Connected to:
Aaron Boros, 31Attila Boros, 70Damian M Boros, 46Hanni L Boros, 44Idaho Boros, 42Janos Boros, 65Joan G Boros, 88Joshua S Boros, 31Julius N Boros, 67Kelly A Boros, 49

Eric Boros Phones & Addresses

  • 824 Mountain Creek Rd, Chapel Hill, NC 27516 (919) 942-1723
  • Durham, NC
  • Charleston, WV
  • Christiansburg, VA
  • Blacksburg, VA
  • Fort Collins, CO
  • 824 Mountain Creek Rd, Chapel Hill, NC 27516

Work

Company: Lord corporation - Cary, NC Sep 2012 Position: Intern

Education

School / High School: North Carolina State University- Raleigh, NC Dec 2012 Specialities: B.S. in Mechanical Engineering

Professional Records

License Records

Eric Sam Boros

License #:
3303004193
Category:
Asbestos Inspector License

Resumes

Resumes

Eric Boros Photo 1

Senior Principal Scientist

View page
Location:
Chapel Hill, NC
Industry:
Pharmaceuticals
Work:
Avista Pharma Solutions, Inc. Sep 2017 - May 2018
Senior Research Scientist
Cambrex May 2018 - Sep 2017
Associate Research Fellow
Pharmacore Sep 2015 - Aug 2017
Senior Principal Scientist
Cambrex Highpoint Sep 2015 - Aug 2017
Senior Principal Scientist
Gsk 2005 - 2015
Group Manager | Section Manager
Education:
Colorado State University 1986 - 1990
Doctorates, Doctor of Philosophy, Philosophy, Chemistry North Carolina State University 1982 - 1986
Bachelors, Bachelor of Science, Chemistry
Skills:
Chemistry
Medicinal Chemistry
Organic Chemistry
Organic Synthesis
Drug Discovery
Hplc
Synthetic Organic Chemistry
Chromatography
Pharmaceutical Industry
Lc Ms
Purification
High Performance Liquid Chromatography
Uv/Vis
Drug Development
Laboratory
Lab Management
Nmr
Nuclear Magnetic Resonance
Eric Boros Photo 2

Eric Boros

View page
Eric Boros Photo 3

Eric Boros Raleigh, NC

View page
Work:
LORD Corporation
Cary, NC
Sep 2012 to Sep 2013
Intern
Applied Research Associates
Raleigh, NC
May 2011 to Aug 2011
Intern
North Carolina State University

Jan 2009 to May 2010
Research Assistant
SpaceDev
Durham, NC
May 2008 to Jul 2008
Intern
Education:
North Carolina State University
Raleigh, NC
Dec 2012
B.S. in Mechanical Engineering

Publications

Us Patents

Condensed Heterocyclic Compounds As Calcitonin Agonists

View page
US Patent:
7189851, Mar 13, 2007
Filed:
Feb 24, 2003
Appl. No.:
10/507006
Inventors:
Ashok Bhandari - Milpitas CA, US
Eric Eugene Boros - Durham NC, US
David John Cowan - Durham NC, US
Anthony Louis Handlon - Durham NC, US
Clifton Earl Hyman - Durham NC, US
Jeffrey Alan Oplinger - Durham NC, US
Michael Howard Rabinowitz - San Diego CA, US
Philip Stewart Turnbull - Durham NC, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07D 471/00
C07D 491/00
C07D 498/00
C07D 513/00
C07D 515/00
US Classification:
546 82, 546 86
Abstract:
The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions.

Ccr5 Antagonists As Therapeutic Agents

View page
US Patent:
7645771, Jan 12, 2010
Filed:
Dec 12, 2003
Appl. No.:
10/538144
Inventors:
Wieslaw Mieczyslaw Kazmierski - Durham NC, US
Chrisopher Joseph Aquino - Durham NC, US
Neil Bifulco - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian Andrew Chauder - Durham NC, US
Pek Yoke Chong - Durham NC, US
Maosheng Duan - Durham NC, US
Felix Deanda, Jr. - Durham NC, US
Cecilia Suarez Koble - Durham NC, US
Ed Williams McLean - Durham NC, US
Jennifer Poole Peckham - Durham NC, US
Angilique C Perkins - Durham NC, US
James Benjamin Thompson - Durham NC, US
Dana Vanderwall - Durham NC, US
Assignee:
SmithKline Beecham Corp. - Philadelphia PA
International Classification:
A61K 31/46
US Classification:
514304, 514319, 546125, 5483101
Abstract:
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).

Chemical Compounds

View page
US Patent:
8222261, Jul 17, 2012
Filed:
Jan 13, 2009
Appl. No.:
12/373524
Inventors:
Subba R Katamreddy - Durham NC, US
Richard Dama Caldwell - Durham NC, US
Dennis Heyer - Durham NC, US
Vincente Samano - Durham NC, US
James Benjamin Thompson - Durham NC, US
Andrew J Carpenter - Durham NC, US
Christopher R Conlee - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian D Thompson - Durham NC, US
Assignee:
GlaxoSmithKline, LLC - Philadelphia PA
International Classification:
A61K 31/519
US Classification:
5142651
Abstract:
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.

Hiv Integrase Inhibitors

View page
US Patent:
20070124152, May 31, 2007
Filed:
Feb 10, 2005
Appl. No.:
10/597902
Inventors:
Brian Johns - Research Triangle Park NC, US
Eric Boros - Research Triangle Park NC, US
Takashi Kawasuji - Osaka, JP
Cecilia Koble - Research Triangle Park NC, US
Noriyuki Kurose - Osaka, JP
Hitoshi Murai - Osaka, JP
Ronald Sherrill - Research Triangle Park NC, US
Jason Weatherhead - Research Triangle Park NC, US
International Classification:
G06Q 99/00
US Classification:
705001000
Abstract:
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.

Glycogen Phosphorylase Inhibitor Compound And Pharmaceutical Composition Thereof

View page
US Patent:
20100305207, Dec 2, 2010
Filed:
Sep 25, 2008
Appl. No.:
12/677846
Inventors:
Pierette Banker - Durham NC, US
Eric Eugene Boros - Durham NC, US
Scott Howard Dickerson - Durham NC, US
Istvan Kaldor - Durham NC, US
Cecilia S. Koble - Durham NC, US
Michael Tolar Martin - Durham NC, US
Steven Meagher Sparks - Durham NC, US
Stephen Andrew Thomson - Durham NC, US
International Classification:
A61K 31/197
C07C 275/42
A61P 3/10
A61P 3/04
A61P 3/06
A61P 9/00
US Classification:
514563, 562439
Abstract:
This invention relates to a novel compound which is a glycogen phosphorylase inhibitor and its use in the treatment of diabetes and other conditions associated therewith. The invention further relates to a pharmaceutical composition containing the compound and to processes for preparing the compound and pharmaceutical composition.

Bis-Pyridylpyridones As Melanin-Concentrating Hormone Receptor 1 Antagonists

View page
US Patent:
20110118261, May 19, 2011
Filed:
Dec 10, 2008
Appl. No.:
12/747186
Inventors:
Scott Allen - Durham NC, US
Eric Boros - Durham NC, US
Jon L. Collins - Durham NC, US
Don Hertzog - Durham NC, US
Xi Liang - Durham NC, US
John Ray - Durham NC, US
Steven Michael Reister - Durham NC, US
Vicente Samano - Durham NC, US
Ron Sherrill - Durham NC, US
International Classification:
A61K 31/5377
C07D 401/14
C07D 413/14
C07D 405/14
A61K 31/444
A61K 31/4545
A61P 3/10
A61P 3/04
A61P 9/12
A61P 25/24
A61P 25/22
A61P 25/30
US Classification:
5142355, 546256, 544131, 546193, 514333, 514318
Abstract:
The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and/or diabetes.

Phenoxathin Derivatives As Inhibitors Of Monoamine Oxidase

View page
US Patent:
61109614, Aug 29, 2000
Filed:
Mar 11, 1999
Appl. No.:
9/254803
Inventors:
Helen Lyng White - late of Chapel Hill NC
Morton Harfenist - Chapel Hill NC
Eric Boros - Chapel Hill NC
Dennis Heyer - Durham NC
Assignee:
Krenitsky Pharmaceuticals, Inc. - Durham NC
International Classification:
A61K 31385
C07D32706
US Classification:
514434
Abstract:
The present invention provide phenoxathiin compounds useful in the prophylaxis and treatment of mental disorders, such as depression. The present invention also provides a method for treating a mammal having depression, anxiety or other conditions responsive to inhibition of MAO-A. A method of preparing the compounds of the present invention is also provided.

Substituted Isoquinolines As Ultra Short Acting Neuromuscular Blockers

View page
US Patent:
61877891, Feb 13, 2001
Filed:
Jan 19, 2000
Appl. No.:
9/381719
Inventors:
Eric Cleveland Bigham - Chapel Hill NC
Grady Evan Boswell - Cary NC
John Joseph Savarese - Southbury CT
Roy Archibald Swaringen - Durham NC
Sanjay Shashikant Patel - Cary NC
Eric Eugene Boros - Chapel Hill NC
Robert Anthony Mook - Chapel Hill NC
Vincente Samano - Chapel Hill NC
Assignee:
Glaxo Wellcome Inc. - Research Triangle Park NC
Cornell Research Foundation Inc. - Ithaca NY
International Classification:
A61K 3147
C07D21702
C07D21706
C07D21712
US Classification:
514308
Abstract:
Ultrashort acting neuromuscular blocking agents of Formula (I) which are useful as skeletal muscle relaxants during emergency intubation procedures, routine surgery and post-operative settings are disclosed, wherein: X is a halogen; h is from 1 to 2; Y is hydrogen or methoxy; Z. sup. 1 and Z. sup. 2 are methyl; W. sup. 1 and W. sup. 2 are carbon; and A is a pharmaceutically acceptable anion.
Control profile
Eric E Boros from Chapel Hill, NC, age ~62 Get Report